Back
CytomX Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40
CTMX
CytomX Therapeutics
Last Price:
$1.08
Seasonality Move:
-0.08%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTMX is experiencing slight selling pressure.
CytomX Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.1 | Sell |
| 20-day SMA: | 1.13 | Sell |
| 50-day SMA: | 1.06 | Buy |
| 200-day SMA: | 1.5 | Sell |
| 8-day EMA: | 1.1 | Sell |
| 20-day EMA: | 1.1 | Sell |
| 50-day EMA: | 1.1 | Sell |
| 200-day EMA: | 1.34 | Sell |
CytomX Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 47.42 | Sell |
| Chaikin Money Flow: | -761657 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.96 - 1.2) | Sell |
| Bollinger Bands (100): | (1.03 - 1.23) | Sell |
CytomX Therapeutics Technical Analysis
| Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for CytomX Therapeutics Stock
Is CytomX Therapeutics Stock a Buy?
-
CytomX Therapeutics share price is 1.07 while CTMX 8-day simple moving average is 1.10, which is a Sell signal.
-
The stock price of CTMX is 1.07 while CytomX Therapeutics 20-day SMA is 1.13, which makes it a Sell.
-
CytomX Therapeutics 50-day simple moving average is 1.06 while CTMX share price is 1.07, making it a Buy technically.
-
CTMX stock price is 1.07 and CytomX Therapeutics 200-day simple moving average is 1.50, creating a Sell signal.
CTMX Technical Analysis vs Fundamental Analysis
Sell
40
CytomX Therapeutics (CTMX)
is a Sell
Is CytomX Therapeutics a Buy or a Sell?
-
CytomX Therapeutics stock is rated a SellThe current CytomX Therapeutics [CTMX] share price is $1.07. The Score for CTMX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
CytomX Therapeutics Stock Info
Market Cap:
83.7M
Price in USD:
1.07
Share Volume:
1.5M
CytomX Therapeutics 52-Week Range
52-Week High:
5.85
52-Week Low:
0.83
Sell
40
CytomX Therapeutics (CTMX)
is a Sell
CytomX Therapeutics Share Price Forecast
-
What is the CytomX Therapeutics stock price today?The CytomX Therapeutics stock price is 1.07 USD today.
-
Will CTMX stock go up or go down?CytomX Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is CytomX Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, CytomX Therapeutics is overvalued.
Is CytomX Therapeutics Stock a Buy?
-
CytomX Therapeutics share price is 1.07 while CTMX 8-day exponential moving average is 1.10, which is a Sell signal.
-
The stock price of CTMX is 1.07 while CytomX Therapeutics 20-day EMA is 1.10, which makes it a Sell.
-
CytomX Therapeutics 50-day exponential moving average is 1.10 while CTMX share price is 1.07, making it a Sell technically.
-
CTMX stock price is 1.07 and CytomX Therapeutics 200-day simple moving average is 1.34, creating a Sell signal.
Fundamental Analysis of CytomX Therapeutics
Is CytomX Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.09 per share, and a decrease next year of $0.44 per share.
Technical Analysis of CytomX Therapeutics
Should I short CytomX Therapeutics stock?
-
CTMX Moving Average Covergence Divergence (MACD) indicator is 0.01, suggesting CytomX Therapeutics is a Buy
-
CytomX Therapeutics Relative Strength Index (RSI) is 47.42, which suggest CytomX Therapeutics is oversold
-
The Bollinger Bands (25) for CytomX Therapeutics is (0.96 - 1.2), which suggest CytomX Therapeutics is a Sell
-
The Bollinger Bands (100) for CytomX Therapeutics is (1.03 - 1.23), which suggest CytomX Therapeutics is a Sell
* CytomX Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.